Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Knowledge Gaps and Barriers to Care in Men with Postprostatectomy Incontinence: Evidence from the German ProKontinenz Trial.

European urology open science·2026

Same author

Prospective registry for patients undergoing artificial urinary sphincter surgery for female stress urinary incontinence due to intrinsic sphincter deficiency: Study protocol.

The French journal of urology·2026

Same author

Reply to 'Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence'.

Nature reviews. Urology·2026

Same author

Penile fracture and concomitant severe urethral trauma-a case report and discussion of surgical approach.

The Canadian journal of urology·2026

Same author

Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.

Scientific reports·2026

Same author

Significant differences in CD276 (B7H3) expression between female and male bladder cancer tissue samples: An exploratory study.

Current urology·2026

Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026

Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026

Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026

Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026

Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026

Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 19, 2026

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

Tissue engineering in urothelium regeneration.

Martin Vaegler¹, Sabine Maurer¹, Patricia Toomey²

¹Laboratory of Tissue Engineering, Department of Urology, Eberhard-Karls-University, Paul-Ehrlich-Str.15, 72076 Tübingen, Germany.

Advanced Drug Delivery Reviews

|December 6, 2014

Summary

This summary is machine-generated.

Tissue engineering for urothelium regeneration faces challenges. Graft tissues show promise over matrices, but cell sourcing and clinical translation require careful consideration.

Keywords:

Cell regeneration Personalized medicine Regenerative medicine Smooth muscle cells Stem cells Tissue engineering Urology Urothelium

More Related Videos

Tissue Engineering of a Human 3D in vitro Tumor Test System

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

Related Experiment Videos

Last Updated: Apr 19, 2026

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

Tissue Engineering of a Human 3D in vitro Tumor Test System

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

Area of Science:

Regenerative Medicine
Urology
Biomaterials Science

Background:

Urothelium regeneration for therapeutic treatments remains a significant challenge in tissue engineering.
Current therapies for urethral defects often inadequately address clinical needs.
Buccal mucosa grafts are a common but not ideal solution for urothelial reconstruction.

Purpose of the Study:

To review primary tissue engineering strategies for urothelium regeneration.
To evaluate promising investigations using grafts, cellular preparations, and biomaterials.
To highlight clinical requirements and challenges in developing in-vivo applications.

Main Methods:

Review of existing literature on tissue engineering for urothelium.
Analysis of strategies involving grafts, cellular preparations, and natural/synthetic materials.
Discussion of scaffold and matrix development.

Main Results:

Graft tissues demonstrate an advantage over matrix-based approaches for urothelium regeneration.
Significant progress in scaffold and matrix development has not yet replaced buccal mucosa transplants.
In vitro cell isolation and propagation require substantial resources and surgical procedures.

Conclusions:

Graft tissues are currently favored over matrices for urothelium regeneration.
Cell source selection is critical to avoid donor site morbidity and ensure safety.
Development of effective therapies requires appropriate animal models and regulatory compliance.